Certain arenaviruses that circulate in rodent populations can cause life-threatening hemorrhagic fevers when they infect humans.Arenaviruses pose a severe risk for outbreaks and might be exploited as biological weapons.
A Saskatoon, Canada organization has been given federal approval to develop a vaccine for deadly African Swine Fever.
Authorities in German states bordering Poland have built fences in an attempt to stop wild boars wandering into Germany and spreading the disease.
For years, researchers who studied Ebola had tried to develop vaccines and drugs to combat the virus. And for years, they had seen promising work stimied by no potential for drug makers to recoup development costs; and the sporardic nature of Ebola outbreaks provided little opportunity to subject experimental vaccines to rigorous tests.
Experts say the grim financial outlook for the few companies still committed to antibiotic research is driving away investors and threatening to strangle the development of new drugs.
The approval for Ervebo was granted to Merck & Co., the American pharmaceutical company that manufactures the vaccine. It was given European Commission approval in November.
The vaccine development process is faster and more efficient than previous methods, which will allow poultry vaccine producers to rapidly update vaccine strains to keep up with virus evolution.
The ability to examine how specific antibodies react with the Ebola virus has led to the development of a drug with far higher survival rates.
The US Department of Health and Human Services (HHS) as issued the first Project BioShield contract to fund the development needed to support the expanded use of an existing antibiotic to treat exposure to inhalational anthrax.
To ensure continued care, the World Health Organization (WHO) has mounted a limited daily helicopter “air bridge” vaccination operation to the communities at risk of violence.